Presentation at the Symposium, "The Next Four Years, the Biotech Agenda, the Human Future: What Direction for Liberals and Progressives?"
By Sheldon Krimsky
| 12. 09. 2004
[summary]
I would like to focus on four points:
1) The discourse on science policy issues has been dominated by two extremist ideologies: libertarianism and conservative fundamentalism, with the former holding that there should be no constraints on science, and the later holding that the constraints on science are determined by religious evangelical principles. These two ideologies have generated the new false idols of the mind: the free market, and faith-based science.
2) These ideologies have staked out separate spheres of influence: the religious conservatives have purview over government policy, and the libertarians have the private sector. So you have two systems of ethics, one for the government and one for the private sector, with the universities straddling both.
3) Traditional sector boundaries are disappearing, notably that between academia and the private market. This has generated a crisis in the integrity of science. Drug manufacturers are running clinical trials of drugs. Manufacturers of cancer drugs are taking over management of cancer treatment centers.
4) The corporate capitalist and the neo-conservative fundamentalist agendas have found their rapproachement: the religious right wants...
Related Articles
By Gina Kolata, The New York Times | 10.21.2024
Kendric Cromer, 12, left Children’s National Hospital in a wheelchair on Wednesday, wearing a T-shirt and cap printed with designs from the anime series “Naruto” and a black face mask. Staff lined the hallway, cheering and waving noisemakers. He had...
By Ashleigh Wyss [cites CGS' Katie Hasson], Listnr | 10.09.2024
Discovering your genetic history can be as simple as spitting into a test tube, but what happens when your data ends up in the wrong hands?
With at-home DNA test kits becoming increasingly popular throughout the 2010s, curious consumers have...
By Nila Bala, Los Angeles Times | 10.21.2024
Turmoil at 23andMe, a company offering popular at-home DNA testing, has upset the industry. Following the resignation of every independent member of the company’s board of directors, its chief executive, Anne Wojcicki, expressed openness to selling the company and its...
By Helena Kudiabor, Nature | 10.14.2024
A study has raised concerns that a type of genetic database that is increasingly popular with researchers could be exploited to reveal the identities of its participants, or link private health information to their public genetic profiles.
Single-cell data sets...